Clinical Trials on 复发难治性 B 细胞淋巴瘤 in China
总计1431个结果
-
Second Military Medical University未知Recurrent B-Cell Tumor | Refractory B-Cell Tumor中国
-
Wuhan Union Hospital, ChinaBeijing GoBroad Hospital Management Co.,Ltd; Shanghai YaKe Biotechnology Ltd.招聘中
-
Shanghai Henlius Biotech完全的
-
The First Affiliated Hospital of Soochow University招聘中
-
Shanghai Cell Therapy Group Co.,Ltd主动,不招人
-
Beijing Tsinghua Chang Gung HospitalChina Immunotech Pharmaceuticals Co.Ltd.暂停
-
Sinocelltech Ltd.未知
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Zhejiang Genfleet Therapeutics Co., Ltd.招聘中
-
Ruijin Hospital招聘中
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.招聘中
-
Hoffmann-La Roche完全的
-
Shanghai Ming Ju Biotechnology Co., Ltd.尚未招聘
-
Fudan University未知肿瘤 | 免疫系统疾病 | 淋巴瘤,B细胞 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴增生性疾病 | 淋巴系统疾病 | 免疫增生性疾病 | 淋巴瘤,非霍奇金 | 吉西他滨 | 顺铂 | 地塞米松 | 利妥昔单抗 | 环磷酰胺 | 西达本胺 | 组织学肿瘤 | HDAC抑制剂中国
-
Xynomic Pharmaceuticals, Inc.招聘中
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Qilu Hospital of Shandong University; Tianjin Medical... 和其他合作者主动,不招人
-
920th Hospital of Joint Logistics Support Force...招聘中
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.招聘中
-
Guangzhou Lupeng Pharmaceutical Company LTD.招聘中
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Ruijiamei Biotechnologies, Co., Ltd.招聘中
-
Ruijin Hospital未知
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Wuhan Union Hospital, ChinaEureka(Beijing) Biotechnology Co., Ltd.主动,不招人
-
Shanghai Ming Ju Biotechnology Co., Ltd.尚未招聘淋巴瘤,大 B 细胞,弥漫性 | 高级别 B 细胞淋巴瘤 | 滤泡性淋巴瘤 3B 级 | 纵隔 B 细胞弥漫性大细胞淋巴瘤中国
-
BeiGene招聘中淋巴瘤 | 白血病 | 小淋巴细胞淋巴瘤 | 难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤 | 复发性慢性淋巴细胞白血病中国
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘
-
Novartis PharmaceuticalsBristol-Myers Squibb招聘中非霍奇金淋巴瘤、弥漫性大 B 细胞淋巴瘤、滤泡性淋巴瘤、套细胞淋巴瘤、边缘区淋巴瘤美国, 德国, 意大利, 大韩民国, 西班牙, 新加坡, 中国, 日本, 澳大利亚
-
The First Affiliated Hospital with Nanjing Medical...主动,不招人
-
Beijing Boren Hospital招聘中复发/复发 | T细胞白血病/淋巴瘤 | 难治性 T 淋巴细胞白血病/淋巴瘤中国
-
Innovative Cellular Therapeutics Co., Ltd.未知
-
The First Affiliated Hospital with Nanjing Medical...Xian-Janssen Pharmaceutical Ltd.未知
-
Hutchison Medipharma Limited未知
-
Novartis Pharmaceuticals主动,不招人
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University Cancer...招聘中年龄范围≥16岁,性别不限 | 组织病理学证实弥漫性大 B 细胞淋巴瘤或高级别 B 细胞淋巴瘤 | 先前接受过 DLBCL 或 HGBL 的一线化疗,四个周期未能达到 CR,或复发 | 根据 2014 年霍奇金和非霍奇金淋巴瘤卢加诺标准至少有一个阳性病变 | ECOG 身体状况评分为 0-3 | 研究人员判断预期寿命至少为三个月 | 了解并自愿签署书面知情同意书中国
-
Hoffmann-La Roche完全的